retatrutide clinical trials obesity New GLP-1 drug, retatrutide, shows added benefits Incretin triple agonist retatrutide (LY3437943)

Researchers dont yet understand exactly how GLP-1 drugs work for AUD, according to Dr

Move Your Body Especially After Eating Exercise isnt just about burning calories its increasingly recognised as one of the most powerful tools for supporting metabolic health, including the hormones that regulate appetite

Laila Gohar (artist): Everyone in L.A

In April 2025 Pfizer was forced to discontinue a clinical trial with one of its experimental GLP-1 medicines to treat obesity due to potential drug induced liver injury found in one of the participants

Mature your revenue cycle management If you're billing insurance, this is the stage where the cracks in your RCM workflow will show up

Exenatide exerts cognitive effects by modulating the BDNF-TrkB neurotrophic axis in adult mice